`
`Page 1
`
` UNITED STATES PATENT AND TRADEMARK OFFICE
`
` BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`__________________________
` )
`MYLAN PHARMACEUTICALS, )
` )
`INC., )
` )
` Petitioner, )
` ) U.S. Patent No.
` vs. ) 7,326,708
` )
`MERCK SHARP & DOHME )
` )
`CORPORATION, )
` )
` Patent Owner. )
` )
`__________________________)
`
` REPORT OF PROCEEDINGS via teleconference
`
`of the above-entitled cause before the Honorable
`
`Timothy G. Majors and Sheridan K. Snedden, Judges
`
`of said Panel, on the 10th day of August, 2020, at
`
`2:32 p.m.
`
`Reported by: Cappy Hallock, RPR, CRR
`
`1
`
`2
`
`3 4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 001
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 2
`
` A P P E A R A N C E S
` (All appearances telephonically)
`
` On behalf of Petitioner Mylan Pharmaceuticals
`
` Inc.:
`
` JITENDRA MALIK, PHD
`
` Katten Muchin Rosenman, LLP
`
` 550 South Tryon Street, Suite 2900
`
` Charlotte, North Carolina 28202
`
` 704-444-2000
`
` jitty.malik@katten.com
`
` On behalf of Petitioner Dr. Reddy's
`
` Laboratories:
`
` RUSSELL W. FAEGENBURG, ESQUIRE
`
` Lerner David Littenberg Krumholz
`
` Mentlik LP
`
` 20 Commerce Drive
`
` Cranford, New Jersey 07016
`
` 908-654-5000
`
` rfaegenburg@lernerdavid.com
`
`1
`
`2 3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 002
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 3
`
`APPEARANCES: (Continued)
`
` On behalf of Petitioners Teva Pharmaceuticals
`
` and Watson Laboratories:
`
` EMILY L. RAPALINO, ESQUIRE
`
` SARAH J. FISCHER, ESQUIRE
`
` Goodwin Procter LLP
`
` 100 Northern Avenue
`
` Boston, Massachusetts 02210
`
` 617-570-1000 (P) 617-523-1231 (F)
`
` erapalino@goodwinlaw.com
`
` sfischer@goodwinlaw.com
`
` On behalf of Petitioner Sun Pharmaceuticals:
`
` JOVIAL WONG, ESQUIRE
`
` CLAIRE A. FUNDAKOWSKI, ESQUIRE
`
` Winston & Strawn LLP
`
` 1901 L Street NW
`
` Washington, D.C. 20036
`
` 202-282-5000
`
` jwong@winston.com
`
` cfundakowski@winston.com
`
`1
`
`2 3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 003
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 4
`
`APPEARANCES: (Continued)
`
` On behalf of the Patent Owner Merck
`
` Sharp & Dohme Corporation:
`
` STANLEY E. FISHER, ESQUIRE
`
` BRUCE R. GENDERSON, ESQUIRE
`
` ELISE M. BAUMGARTEN, ESQUIRE
`
` Williams & Connolly LLP
`
` 725 12th Street, NW
`
` Washington, D.C. 20005-5901
`
` 202-434-5000
`
` sfisher@wc.com, bgenderson@wc.com,
`
` ebaumgarten@wc.com
`
`Court Reporter:
`
`Cappy Hallock, RPR, CRR
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`1
`
`2 3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Mylan (IPR2020-00040) Ex. 1018 p. 004
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 5
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
` P R O C E E D I N G S
`
` - - - - - -
`
` JUDGE MAJORS: We are here today for a
`
`conference call related to a number of petitions,
`
`including IPR2020-00040 and other related
`
`petitions, challenging the same patent,
`
`IPR2020-01045, -01060 and -01072.
`
` It sounded to me like we have counsel
`
`for the Petitioners in each of those cases as well
`
`as Merck's counsel on as well, so why don't we
`
`kick things off.
`
` We have looked at the request. It
`
`looks as though the parties have filed a
`
`stipulation to change, to modify some of the
`
`dates, and based on the request sent via e-mail
`
`it's only that portion of due date 2 that the
`
`parties need Board authorization to change that is
`
`at issue at the moment.
`
` So with that, Mr. Malik, I don't know
`
`if you will be speaking on the Petitioners' part,
`
`and Mr. Fisher, if you will be speaking on Merck's
`
`part, why don't we kick things off and I will open
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 005
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 6
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`the floor up to Patent Owner first.
`
` MR. FISHER: Sure, Your Honor. I
`
`think you have it spot on. I think there is a
`
`stip that Mylan and Patent Owner Merck put on file
`
`on Friday to move due date 1 by one week. And you
`
`are right, Your Honor, it is this call where Mylan
`
`and Merck jointly I think seek leave to move the
`
`portion of due date 2, which I think is due date
`
`2B, to extend that by a week as well. So I think
`
`that probably would be the easiest part of this
`
`call.
`
` MR. MALIK: Mylan agrees with Merck's
`
`petition. Basically we reached agreement on the
`
`due dates that we could move by a week. That was
`
`most of the issues that we were going to bring
`
`today before Your Honor, and then due date 2A we
`
`just need your permission to move it back one week
`
`per the scheduling order. I think that's the only
`
`thing on the table as it relates to the scheduling
`
`issues.
`
` JUDGE MAJORS: And that modification
`
`to the schedule is not opposed by anyone; is that
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 006
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 7
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`right?
`
` Hello? Did I drop off?
`
` (Unidentified speaking.)
`
` SPEAKER: No, no, no. Not that we are
`
`aware of.
`
` MR. MALIK: I took the silence as no
`
`one is aware of --
`
` THE REPORTER: Gentlemen, when you
`
`speak I will need you to identify yourselves.
`
` MR. MALIK: Sure. That was Jitendra
`
`Malik for Mylan. Sorry, court reporter.
`
` THE REPORTER: Thank you.
`
` JUDGE MAJORS: All right, this is
`
`Judge Majors. We will then go ahead. We will
`
`authorize the change to that part of due date 2 to
`
`line up with the other stipulated changes to the
`
`due date, which I guess is, what, moving it to
`
`November 21st then?
`
` MR. MALIK: November 13th.
`
` JUDGE MAJORS: November 15th?
`
` MR. MALIK: 13th.
`
` JUDGE MAJORS: Hold on, give me one
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 007
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 8
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`second.
`
` Okay, you are right. I'm sorry, I had
`
`written it down wrong. So from the 6th to the
`
`13th.
`
` MR. MALIK: Yes, Your Honor.
`
` JUDGE MAJORS: All right, is there
`
`anything else from the parties' perspectives that
`
`we needed to raise on today's call?
`
` MR. FISHER: Your Honor, this is Stan
`
`Fisher. I think we wanted to simply update Your
`
`Honors as to where things stood from our
`
`perspective with respect to joinder. I'm not sure
`
`that there is anything we necessarily need to
`
`resolve today. We, if you recall we had a
`
`discussion a few weeks back, maybe even a month
`
`ago now, about the joinder process and attempting
`
`to expedite it to potentially reach some
`
`resolution before our Patent Owner response was
`
`due.
`
` Briefing has been completed on the
`
`joinder motions filed by Joinder Petitioners, and
`
`I believe that as of the reply brief going in,
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 008
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 9
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Merck can report that we see that there is
`
`agreement amongst Merck and the Joinder
`
`Petitioners on the understudy role that the
`
`Joinder Petitioners would play. We had a brief
`
`conferral call after that reply brief went in and
`
`I think we were able to confirm that in fact we
`
`are in agreement on the various understudy
`
`conditions which I believe are reported in the
`
`various briefs and correspondence between the
`
`parties.
`
` I think that the one aspect that was
`
`outstanding from Merck's position was what to do,
`
`if anything, about the sequencing of party
`
`discovery and, you know, I can report from Merck's
`
`perspective my understanding is, and I will let my
`
`counterparts representing Mylan and Teva can
`
`certainly speak for themselves, but my
`
`understanding is that Mylan is not intending to
`
`rely on Dr. Len Chyll who is the declarant that
`
`Teva submitted a declaration on behalf of them.
`
`My understanding is that as of this morning Teva
`
`has withdrawn the declaration of Dr. Chyll in view
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 009
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 10
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`of the fact that Mylan's declarant, Dr. Torgotti,
`
`was deposed last week.
`
` You know, at this point in time we
`
`don't oppose joinder on the basis of the fact that
`
`if we were to seek discovery it wouldn't happen
`
`until after joinder is granted. We would like to
`
`make clear that we certainly would reserve the
`
`right to seek discovery if joinder is ordered by
`
`the Board. I think the Board has referenced in
`
`the past that perhaps these issues of making use
`
`of any discovery, if discovery is made available,
`
`could be dealt with in a surreply or a
`
`supplemental brief of some sort.
`
` So I wanted to update the Board as to
`
`where Merck stood at this point in time as it
`
`doesn't look like any of this is going to happen
`
`before our Patent Owner response would be due,
`
`would be due in, I guess, a little under two weeks
`
`now. So I will stop there.
`
` JUDGE MAJORS: Thank you for that,
`
`Mr. Fisher. I was going to ask you, or ask the
`
`parties about the status on the joinder issues. I
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 010
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 11
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`have looked at the papers, and as we talked about
`
`at length last time -- we don't need to go through
`
`all the details again, but it's good to hear I
`
`guess there is agreement in principal on the
`
`understudy role -- and if I hear you correctly it
`
`seems that Merck is saying well, you don't oppose
`
`joinder but you are reserving your right vis-à-vis
`
`the discovery that is mentioned in the various
`
`papers -- and I will swing back to you in a second
`
`and you can tell me if that's wrong -- in which
`
`case I think then the only outstanding issue for
`
`the Board in getting to the joinder motion is what
`
`Patent Owner is going to do relative to the
`
`preliminary response in those other three cases.
`
` I know when we spoke last time I asked
`
`what Patent Owner's intention was and I think it
`
`was something to the effect that well, we are not
`
`thinking about filing that but it was -- I don't
`
`think it was set in stone at that time.
`
` But via statute, Section 315, we have
`
`to either wait for the Patent Owner's preliminary
`
`response to come in or for the time to pass or I
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 011
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 12
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`guess alternatively get some paper saying for
`
`Patent Owner's part we are not going to file -- we
`
`are reserving our right but we are not going to
`
`file a Patent Owner preliminary response so we can
`
`move on to address the joinder issues.
`
` All that being said, I will turn it
`
`back to you, Mr. Fisher, first, to see if Patent
`
`Owner is not going to file a preliminary response
`
`and we can get on with the joinder issue then I
`
`think we will need some affirmative filing from
`
`Patent Owner to make that a record.
`
` MR. FISHER: This is Stan Fisher.
`
` Fair enough, Your Honor. I don't
`
`believe we intend to file any preliminary response
`
`but certainly can put a paper on file to that
`
`effect after, you know, finally conferring with
`
`our client on the point. But, yes, I believe
`
`that's where we are at right now.
`
` JUDGE MAJORS: Okay. As soon as we
`
`get that paper in we can move on to addressing the
`
`joinder issue I think relatively quickly. But
`
`unless we get something confirming that no
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 012
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 13
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`preliminary response is coming in we are in a
`
`little bit of a limbo right now.
`
` MR. FISHER: Okay. This is Stan
`
`Fisher. To be quite honest, I didn't realize that
`
`was the one thing holding things up and had I
`
`realized that we would have put something in much
`
`sooner. Absolutely we will get something in as
`
`soon as I can.
`
` JUDGE MAJORS: Okay.
`
` And not to monopolize the call,
`
`anything from you, Mr. Malik, or any of the other
`
`Petitioners that need to speak up?
`
` MR. MALIK: This is Mr. Malik.
`
` Nothing specific, Your Honor.
`
`Obviously we will reserve our rights regarding any
`
`discovery they may raise in connection with any of
`
`the other Joint Petitioners and Dr. Chyll. As
`
`Mr. Fisher notes, our expert is Dr. Torgotti.
`
`That's the one, the expert that provided the
`
`declaration with our petition. He was deposed
`
`last week. So basically we will cross the
`
`remaining bridges when we get to it if and when
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 013
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 14
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Merck decides to file any discovery motion and so
`
`on and so forth.
`
` JUDGE MAJORS: Okay.
`
` Anything for the other Petitioners? I
`
`know you are taking an understudy role but is
`
`there anything you need to raise at the moment?
`
` MS. RAPALINO: This is Emily Rapalino
`
`for the Teva and Watson Petitioners. There is
`
`nothing from us. Mr. Fisher covered the update of
`
`where we are, and I think in light of the fact
`
`that there are no more disputes with respect to
`
`the understudy role and the parties seem to be in
`
`agreement that we can address the discovery issues
`
`at a later date after the joinder issue is
`
`resolved I don't think there is anything further
`
`from us.
`
` JUDGE MAJORS: Well, thank you for
`
`that.
`
` So then, Mr. Fisher, we will just be
`
`on the lookout, then. Obviously check with the
`
`client and make sure that the Patent Owner is in
`
`fact not going to file anything, but you can file
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 014
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 15
`
`it however you want. You can call it a
`
`preliminary response and just refer to what
`
`happened earlier. You can, you know, reserve your
`
`rights, and of course you disagree with the
`
`challenge and with the Board, the Board paper for
`
`institution, but you will waive this particular
`
`filing and address it in the Patent Owner
`
`response.
`
` Just so we have something so we know
`
`and can move on so we can get over that 315
`
`hurdle.
`
` MR. FISHER: Absolutely, Your Honor.
`
`This is Stan Fisher. We will do exactly that.
`
` JUDGE MAJORS: Okay.
`
` All right, well, thank you everyone.
`
`Unless there is anything further why don't we
`
`adjourn. Every one enjoy the rest of the day.
`
` ALL: Thank you, Your Honor.
`
` (Off the record at 2:45 p.m.)
`
` - - - - - - -
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 015
`
`
`
`PROCEEDINGS - August 10, 2020
`
`Page 16
`
`UNITED STATES OF AMERICA )
`
`STATE OF MARYLAND )
`
` I, CAPPY HALLOCK, the reporter before
`
`whom the foregoing proceedings were taken, do
`
`hereby certify that the foregoing transcript is a
`
`true record of the proceedings.
`
` I further certify that I am neither
`
`counsel for, related to, nor employed by any of
`
`the parties to the action in which these
`
`proceedings were taken; and further that I am not
`
`a relative or employee of any attorney or counsel
`
`employed by the parties hereto, or financially or
`
`otherwise interested in the outcome of this
`
`action.
`
` _______________________
`
` Cappy Hallock, RPR, CRR
`
`My Commission expires January 19, 2021
`
`1
`
`2
`
`3 4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`GregoryEdwards, LLC | Worldwide Court Reporting
`GregoryEdwards.com | 866-4Team GE
`
`Mylan (IPR2020-00040) Ex. 1018 p. 016
`
`